Diagnosis and treatment of reentrant atrial tachycardia at the superior vena cava–right atrium junction using a dual-energy lattice-tip catheter Authors: Masatsugu Nozoe, Takanori Watanabe, Takeru Ikenaga, Satoshi Tsujioka, Hiroshi Mannoji, Nobuhiro Suematsu, Toru Kubota Published: 2026 Key Teaching Points •High-density mapping with a dual-energy lattice-tip catheter was useful for diagnosing reentrant atrial tachycardia involving the superior vena cava–right atrium junction and identifying the presumed critical isthmus. High-density mapping with a dual-energy lattice-tip catheter was useful for diagnosing reentrant atrial tachycardia involving the superior vena cava–right atrium junction and identifying the presumed critical isthmus. •Mapping during sinus rhythm can clarify the relationship between the critical isthmus and the earliest sinus activation site, which may be useful for planning pulsed-field ablation while avoiding sinus node injury. Mapping during sinus rhythm can clarify the relationship between the critical isthmus and the earliest sinus activation site, which may be useful for planning pulsed-field ablation while avoiding sinus node injury. •A dual-energy lattice-tip catheter could perform pulsed-field ablation of superior vena cava–related arrhythmia substrates without sinus node dysfunction or phrenic nerve palsy in this case. A dual-energy lattice-tip catheter could perform pulsed-field ablation of superior vena cava–related arrhythmia substrates without sinus node dysfunction or phrenic nerve palsy in this case. Introduction The Affera dual-energy lattice-tip platform has demonstrated efficacy for atrial fibrillation (AF) ablation and for creation of linear lesions, integrating high-density mapping and focal pulsed-field ablation (PFA) within a single catheter.1,2 In contrast, published experience with the Affera platform for reentrant atrial arrhythmias remains limited, and its role in treatment within the superior vena cava (SVC) has yet to be established. Case report A 72-year-old man with a history of pulmonary vein (PV) isolation using cryoballoon ablation 10 years earlier was referred for repeat ablation because of recurrent AF. The patient was taking irbesartan 100 mg once daily, nifedipine controlled-release 40 mg once daily, and edoxaban 60 mg once daily. Because sinus rhythm could not be restored despite intracardiac cardioversion, voltage mapping was performed during ongoing AF using the Affera system and Sphere-9 catheter (Medtronic, Minneapolis, MN). Voltage mapping during AF demonstrated reconnection of the left inferior and right inferior PVs; however, the precise reconnection sites could not be determined. Reisolation of both PVs was performed using an encircling PFA approach with the Sphere-9 catheter. After PV reisolation, intracardiac cardioversion transiently restored sinus rhythm, but atrial tachycardia (AT) was spontaneously initiated immediately. High-density mapping using the Affera system demonstrated a reentrant circuit at the SVC–right atrium (RA) junction (Figure 1A). The activation sequence in the left atrium was consistent with passive activation from the RA (Figure 1B). The voltage map during AT showed 2 separate low-voltage areas at the SVC-RA junction (Figure 1C). When interpreted together with the activation map, the area between these low-voltage regions was considered to represent the critical isthmus. The Sphere-9 catheter acquires closed-unipolar electrograms from multiple surface microelectrodes referenced to a central indifferent electrode. The recorded electrograms spanned a relatively wide range of the tachycardia cycle length, suggesting a reentrant circuit confined to a limited region around the SVC-RA junction (Figure 2A). The postpacing interval recorded by the Sphere-9 catheter positioned at the SVC-RA junction was nearly identical to the tachycardia cycle length (Figures 2B and 3). After spontaneous termination of AT, both atrial and SVC potentials were recorded on a single electrode of the Affera Sphere-9 catheter, indicating that the recording site was located at the SVC-RA junction. A spiky fragmented potential was observed between these potentials, suggesting the critical isthmus of the reentrant circuit (Figure 4A). The earliest activation site during sinus rhythm was confirmed by high-density mapping with the Affera system (Figure 4B). A circumferential white line drawn at the level of the critical isthmus of the reentrant circuit was superimposed on the sinus activation map. This demonstrated that the critical isthmus was located approximately 2 cm cranial to the earliest sinus activation site and sufficiently distant from the sinus node. Voltage mapping performed during sinus rhythm revealed long myocardial sleeves extending into the SVC and demonstrated an oblique low-voltage area at the presumed SVC-RA junction (Figure 4C). Because a previous case series using a circular multielectrode array catheter demonstrated the safety and efficacy of PFA targeting 2 cm cranial to the earliest sinus activation site,3 circumferential PFA along this line was planned with a 2-cm margin to avoid sinus node dysfunction. Circumferential PFA was performed at the SVC-RA junction (Figure 5A and 5B), and postablation mapping confirmed adequate lesion formation (Figure 5C and 5D). The earliest activation site during sinus rhythm did not change after PFA compared with before ablation. The heart rate during sinus rhythm remained unchanged after PFA. The procedure was concluded after confirming that no tachyarrhythmia was inducible. Chest radiography on the next day revealed no phrenic nerve palsy. High-density mapping of atrial tachycardia (AT). A: High-density mapping of AT with Affera mapping system demonstrated a reentrant circuit at the superior vena cava (SVC)–right atrium (RA) junction. B: The activation sequence in the left atrium was consistent with passive activation from the RA. C: The voltage map during AT showed 2 separate low-voltage areas at the SVC-RA junction. When interpreted together with the activation map, the area between these low-voltage regions was considered to represent the critical isthmus. Electrograms recorded with the Affera Sphere-9 catheter. A: The Sphere-9 catheter acquires closed-unipolar electrograms from multiple surface microelectrodes referenced to a central indifferent electrode. The recorded electrograms spanned a relatively wide range of the tachycardia cycle length, suggesting a reentrant circuit confined to a limited region around the superior vena cava (SVC)–right atrium (RA) junction. Electrograms recorded at P4, D4, D2, D1, and the tip electrode (red arrows) revealed fragmented potentials. A diagnostic high RA (HRA)–coronary sinus (CS) catheter was placed through the right jugular vein into the CS. The HRA electrodes (7–8 proximal and 1–2 distal) and the CS electrodes (7–8 proximal and 1–2 distal) are shown from top to bottom at a paper speed of 100 mm/s. B: The postpacing interval recorded by the Sphere-9 catheter positioned at the SVC-RA junction was nearly identical to the tachycardia cycle length. Fluoroscopic view. Left anterior oblique (A) and right anterior oblique (B) fluoroscopic views of the Affera Sphere-9 catheter positioned at the superior vena cava (SVC)–right atrium (RA) junction. A diagnostic high RA–coronary sinus catheter was placed through the right jugular vein into the coronary sinus. Contrast medium was injected through the sheath into the SVC. Spontaneous termination of atrial tachycardia. A: After spontaneous termination of atrial tachycardia, both atrial and superior vena cava (SVC) potentials were recorded on a single electrode of the Affera Sphere-9 catheter, indicating that the recording site was located at the SVC-RA junction. A spiky fragmented potential was observed between these potentials (red arrows), suggesting the critical isthmus of the reentry. B: The earliest activation site during sinus rhythm was confirmed by high-density mapping with the Affera system. A circumferential white line is shown on the sinus rhythm activation map at the level of the critical isthmus of the reentry. This line was approximately 2 cm cranial to the earliest activation site during sinus rhythm; circumferential PFA along this line was planned with a 2-cm margin to avoid sinus node dysfunction. C: Voltage mapping performed during sinus rhythm revealed long myocardial sleeves extending into the superior vena cava (SVC) and demonstrated an oblique low-voltage area at the presumed SVC-RA junction. Isolation of superior vena cava. A and B: Pulsed-field ablation (PFA) was delivered during sinus rhythm along a circumferential white line corresponding to the level of the critical isthmus of the reentrant circuit. Additional applications were delivered until the lesion tags were evenly distributed circumferentially. Postablation activation mapping (C) and voltage mapping (D) confirmed adequate lesion formation with the Affera Sphere-9 catheter. The earliest activation site during sinus rhythm did not change after PFA compared with before ablation. Heart rate remained unchanged both immediately after PFA and after discharge. Discussion This case demonstrates the clinical utility of the Affera mapping system and Sphere-9 catheter for both diagnosis and treatment of an unusual AT involving the SVC-RA junction. High-density mapping allowed detailed assessment of the reentrant circuit and its relationship to the sinus node. In addition, to the best of our knowledge, this case represents the first report focusing on SVC-region treatment using the Affera system and Sphere-9 catheter. The mechanism of this AT was considered to be reentry involving the SVC-RA junction. In the present case, voltage mapping during sinus rhythm demonstrated an oblique low-voltage area at the presumed SVC-RA junction.4 This area may have served as a substrate for conduction block and slow conduction. In addition, voltage mapping during AT demonstrated a low-voltage area around the presumed critical isthmus, which provided a clearer understanding of the reentrant circuit and the location of the critical isthmus. Interestingly, the voltage maps obtained during sinus rhythm and AT showed different appearances. This finding suggests that the critical isthmus may not have been explained solely by a fixed anatomic low-voltage substrate, but may also have involved a functional component, such as rate-dependent conduction slowing or functional block. Therefore, high-density mapping using the Affera system was useful for understanding the reentrant circuit and identifying the region most likely responsible for maintenance of the tachycardia. Radiofrequency ablation in the SVC region carries a risk of phrenic nerve injury,5 whereas PFA may reduce collateral damage because of its tissue-selective properties. Nevertheless, sinus node dysfunction remains an important concern when treating arrhythmias near the SVC-RA junction. In the present case, spontaneous termination of AT allowed high-density mapping during sinus rhythm, which enabled identification of the earliest sinus activation site. This confirmed that the critical isthmus of the AT was located approximately 2 cm cranial to this site. Because a previous case series using a circular multielectrode array catheter demonstrated the safety and efficacy of PFA targeting the SVC 2 cm cranial to the earliest sinus activation site, we considered that a similar strategy could be applied in the present case. Circumferential PFA at this level was expected to treat the critical isthmus of the AT and achieve SVC isolation while maintaining an adequate distance from the presumed sinus node region. We selected SVC isolation rather than focal ablation of the critical isthmus alone because this strategy might reduce the risk of AT/AF recurrence by treating the SVC as a possible non-PV trigger source for AF.3, 4, 5 In this case, SVC isolation was successfully achieved using the Affera system and Sphere-9 catheter without sinus node dysfunction or phrenic nerve palsy. Disclosures Dr Masatsugu Nozoe reports receiving speaker fees from Medtronic, Boston Scientific, and Japan Lifeline. All other authors declare no conflicts of interest. Acknowledgments Funding Sources This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors. Patient Consent A written informed consent was obtained from the patient for publication of this case report and any accompanying images in accordance with Committee on Publication Ethics guidelines. References